These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7957192)

  • 1. Chimeras of the human cytochrome P450 1A family produced in yeast. Accumulation in microsomal membranes, enzyme kinetics and stability.
    Bellamine A; Gautier JC; Urban P; Pompon D
    Eur J Biochem; 1994 Nov; 225(3):1005-13. PubMed ID: 7957192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-aminobenzanthrone, a human metabolite of the environmental pollutant 3-nitrobenzanthrone, forms DNA adducts after metabolic activation by human and rat liver microsomes: evidence for activation by cytochrome P450 1A1 and P450 1A2.
    Arlt VM; Hewer A; Sorg BL; Schmeiser HH; Phillips DH; Stiborova M
    Chem Res Toxicol; 2004 Aug; 17(8):1092-101. PubMed ID: 15310241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of human cytochromes P450 1A1 and P450 1A2 as fused enzymes with yeast NADPH-cytochrome P450 oxidoreductase in transgenic tobacco plants.
    Shiota N; Kodama S; Inui H; Ohkawa H
    Biosci Biotechnol Biochem; 2000 Oct; 64(10):2025-33. PubMed ID: 11129571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional expression of fused enzymes between human cytochrome P4501A1 and human NADPH-cytochrome P450 oxidoreductase in Saccharomyces cerevisiae.
    Wittekindt NE; Würgler FE; Sengstag C
    DNA Cell Biol; 1995 Apr; 14(4):273-83. PubMed ID: 7710684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of human lung microsomal cytochrome P-450 1A1 and its role in the oxidation of chemical carcinogens.
    Shimada T; Yun CH; Yamazaki H; Gautier JC; Beaune PH; Guengerich FP
    Mol Pharmacol; 1992 May; 41(5):856-64. PubMed ID: 1588920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of modified human cytochrome P450 1A1 in Escherichia coli: effects of 5' substitution, stabilization, purification, spectral characterization, and catalytic properties.
    Guo Z; Gillam EM; Ohmori S; Tukey RH; Guengerich FP
    Arch Biochem Biophys; 1994 Aug; 312(2):436-46. PubMed ID: 8037457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two distinct sequences control the targeting and anchoring of the mouse P450 1A1 into the yeast endoplasmic reticulum membrane.
    Cullin C
    Biochem Biophys Res Commun; 1992 May; 184(3):1490-5. PubMed ID: 1590806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High promutagen activating capacity of yeast microsomes containing human cytochrome P-450 1A and human NADPH-cytochrome P-450 reductase.
    Sengstag C; Eugster HP; Würgler FE
    Carcinogenesis; 1994 May; 15(5):837-43. PubMed ID: 8200084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of modified human cytochrome P450 1A2 in Escherichia coli: stabilization, purification, spectral characterization, and catalytic activities of the enzyme.
    Sandhu P; Guo Z; Baba T; Martin MV; Tukey RH; Guengerich FP
    Arch Biochem Biophys; 1994 Feb; 309(1):168-77. PubMed ID: 8117105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Cloning, Tissue Distribution, and Functional Characterization of Marmoset Cytochrome P450 1A1, 1A2, and 1B1.
    Uehara S; Uno Y; Inoue T; Sasaki E; Yamazaki H
    Drug Metab Dispos; 2016 Jan; 44(1):8-15. PubMed ID: 26502772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High efficiency family shuffling based on multi-step PCR and in vivo DNA recombination in yeast: statistical and functional analysis of a combinatorial library between human cytochrome P450 1A1 and 1A2.
    Abécassis V; Pompon D; Truan G
    Nucleic Acids Res; 2000 Oct; 28(20):E88. PubMed ID: 11024190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1A1: a comparison of the activities induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in MCF-7 cells with those from heterologous expression of the cDNA.
    Spink DC; Eugster HP; Lincoln DW; Schuetz JD; Schuetz EG; Johnson JA; Kaminsky LS; Gierthy JF
    Arch Biochem Biophys; 1992 Mar; 293(2):342-8. PubMed ID: 1536570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes.
    Foroozesh M; Primrose G; Guo Z; Bell LC; Alworth WL; Guengerich FP
    Chem Res Toxicol; 1997 Jan; 10(1):91-102. PubMed ID: 9074808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A genetically engineered P450 monooxygenase: construction of the functional fused enzyme between rat cytochrome P450c and NADPH-cytochrome P450 reductase.
    Murakami H; Yabusaki Y; Sakaki T; Shibata M; Ohkawa H
    DNA; 1987 Jun; 6(3):189-97. PubMed ID: 3109864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol is a selective human cytochrome P450 1A1 inhibitor.
    Chun YJ; Kim MY; Guengerich FP
    Biochem Biophys Res Commun; 1999 Aug; 262(1):20-4. PubMed ID: 10448061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of cytochrome P450 1A1 and 1A2 by hyperoxia.
    Okamoto T; Mitsuhashi M; Fujita I; Sindhu RK; Kikkawa Y
    Biochem Biophys Res Commun; 1993 Dec; 197(2):878-85. PubMed ID: 8267628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrostatic interaction between cytochrome P450 and NADPH-P450 reductase: comparison of mixed and fused systems consisting of rat cytochrome P450 1A1 and yeast NADPH-P450 reductase.
    Kondo S; Sakaki T; Ohkawa H; Inouye K
    Biochem Biophys Res Commun; 1999 Apr; 257(2):273-8. PubMed ID: 10198202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of mutations of ionic amino acids of cytochrome P450 1A2 on catalytic activities toward 7-ethoxycoumarin and methanol.
    Mayuzumi H; Sambongi C; Hiroya K; Shimizu T; Tateishi T; Hatano M
    Biochemistry; 1993 Jun; 32(21):5622-8. PubMed ID: 8504082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of P450 1A1 and P450 1A2 in bioactivation versus detoxication of the renal carcinogen aristolochic acid I: studies in Cyp1a1-/-, Cyp1a2-/-, and Cyp1a1/1a2-/- mice.
    Arlt VM; Levová K; Bárta F; Shi Z; Evans JD; Frei E; Schmeiser HH; Nebert DW; Phillips DH; Stiborová M
    Chem Res Toxicol; 2011 Oct; 24(10):1710-9. PubMed ID: 21932800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetically engineered modification of P450 monooxygenases: functional analysis of the amino-terminal hydrophobic region and hinge region of the P450/reductase fused enzyme.
    Yabusaki Y; Murakami H; Sakaki T; Shibata M; Ohkawa H
    DNA; 1988 Dec; 7(10):701-11. PubMed ID: 3148446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.